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Background: We assessed 5-year outcomes after implantation of sirolimus-eluting stent (SES) for unprotected left main coronary artery (ULMCA) 
disease in comparison with that for non-left main disease.
methods and results: The j-Cypher is a multicenter prospective registry of consecutive patients undergoing SES implantation in Japan. Among 
12,812 patients enrolled in the j-Cypher registry, unadjusted mortality rate at 5 years was significantly higher in patients with ULMCA stenting 
(n=582) than in patients without ULMCA stenting (n=12230) (22.8% versus 14.1%, P<0.0001); however, the risk of ULMCA stenting for death was no 
longer significant after adjusting for confounders (hazard ratio 1.18, 95% confidence interval 0.95 to 1.46, P=0.14). In the lesion-level comparison, 
the 96 non-bifurcation ULMCA lesions treated exclusively with SES had a significantly lower rate of target-lesion revascularization (TLR) than those in 
non-ULMCA non-bifurcation lesions (n=13249) (2.4% versus 12.7%, P=0.04). Among bifurcation lesions, those treated with provisional two-approach 
had similar rates of TLR (12.1% versus 11.4%; P=0.79) between the ULMCA (n=281) and non-ULMCA (n=1433) groups. Lesions treated with elective 
two stent had higher TLR rates in ULMCA group (n=99) as compared with non-ULMCA group (n=217) (33.5% versus 19.7%, P=0.002).
conclusions: The safety of ULMCA stenting relative to non-LMCA stenting was maintained through 5 years follow-up. In terms of efficacy, SES 
implantation in non-bifurcation ULMCA lesions was associated with an extremely low cumulative incidence of TLR, while elective two-stent approach 
for ULMCA bifurcation lesions was associated with markedly higher cumulative incidence of TLR as compared with that for non-ULMCA bifurcation 
lesions.
